CEACAM5 and pancreatic neoplasm: Knutson et al. used a CEA-targeting mouse mAb conjugated with a near-infrared fluorophore and paclitaxel and showed that this ADC could be tracked in vitro and in vivo and was internalized by BxPC-3 pancreatic cancer cells [38].